Publications in collaboration with researchers from Universidade de Lisboa (2)

2017

  1. TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 6, pp. 1898-1907

2014

  1. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 99, Núm. 5